342 related articles for article (PubMed ID: 16882752)
1. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.
Oktay K; Hourvitz A; Sahin G; Oktem O; Safro B; Cil A; Bang H
J Clin Endocrinol Metab; 2006 Oct; 91(10):3885-90. PubMed ID: 16882752
[TBL] [Abstract][Full Text] [Related]
2. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.
Oktay K; Buyuk E; Libertella N; Akar M; Rosenwaks Z
J Clin Oncol; 2005 Jul; 23(19):4347-53. PubMed ID: 15824416
[TBL] [Abstract][Full Text] [Related]
3. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.
Azim AA; Costantini-Ferrando M; Lostritto K; Oktay K
J Clin Endocrinol Metab; 2007 Jun; 92(6):2197-200. PubMed ID: 17356042
[TBL] [Abstract][Full Text] [Related]
4. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
[TBL] [Abstract][Full Text] [Related]
5. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
Azim AA; Costantini-Ferrando M; Oktay K
J Clin Oncol; 2008 Jun; 26(16):2630-5. PubMed ID: 18509175
[TBL] [Abstract][Full Text] [Related]
6. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
Fatum M; McVeigh E; Child T
Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119
[TBL] [Abstract][Full Text] [Related]
7. High yield of oocytes without an increase in circulating estradiol levels in breast cancer patients treated with follicle-stimulating hormone and aromatase inhibitor in standard gonadotropin-releasing hormone analogue protocols.
Ben-Haroush A; Farhi J; Ben-Aharon I; Sapir O; Pinkas H; Fisch B
Isr Med Assoc J; 2011 Dec; 13(12):753-6. PubMed ID: 22332446
[TBL] [Abstract][Full Text] [Related]
8. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†.
Pereira N; Hancock K; Cordeiro CN; Lekovich JP; Schattman GL; Rosenwaks Z
Gynecol Endocrinol; 2016 Oct; 32(10):823-826. PubMed ID: 27114051
[TBL] [Abstract][Full Text] [Related]
10. Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?
Revelli A; Porcu E; Levi Setti PE; Delle Piane L; Merlo DF; Anserini P
Gynecol Endocrinol; 2013 Nov; 29(11):993-6. PubMed ID: 24000936
[TBL] [Abstract][Full Text] [Related]
11. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.
Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K
Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104
[TBL] [Abstract][Full Text] [Related]
12. Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study.
Courbiere B; Decanter C; Bringer-Deutsch S; Rives N; Mirallié S; Pech JC; De Ziegler D; Carré-Pigeon F; May-Panloup P; Sifer C; Amice V; Schweitzer T; Porcu-Buisson G; Poirot C;
Hum Reprod; 2013 Sep; 28(9):2381-8. PubMed ID: 23832792
[TBL] [Abstract][Full Text] [Related]
13. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
Goswami SK; Das T; Chattopadhyay R; Sawhney V; Kumar J; Chaudhury K; Chakravarty BN; Kabir SN
Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
[TBL] [Abstract][Full Text] [Related]
14. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
15. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.
Das M; Shehata F; Son WY; Tulandi T; Holzer H
Hum Reprod; 2012 Aug; 27(8):2509-14. PubMed ID: 22617122
[TBL] [Abstract][Full Text] [Related]
16. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma.
Azim A; Oktay K
Fertil Steril; 2007 Sep; 88(3):657-64. PubMed ID: 17428480
[TBL] [Abstract][Full Text] [Related]
17. The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women.
Checa Vizcaíno MA; Corchado AR; Cuadri ME; Comadran MG; Brassesco M; Carreras R
Reprod Biomed Online; 2012 Jun; 24(6):606-10. PubMed ID: 22503276
[TBL] [Abstract][Full Text] [Related]
18. The effects of letrozole on women with endometriosis undergoing ovarian stimulation for
Kim SJ; Choo CW; Kim SK; Lee JR; Jee BC; Suh CS; Lee WD; Kim SH
Gynecol Endocrinol; 2020 Mar; 36(3):257-260. PubMed ID: 31389274
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Study of Letrozole Treatment Prior to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization at Risk of Ovarian Hyperstimulation Syndrome.
Chen Y; Yang T; Hao C; Zhao J
Med Sci Monit; 2018 Jun; 24():4248-4253. PubMed ID: 29925074
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
